Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole

Gynecol Oncol. 2004 Dec;95(3):769-71. doi: 10.1016/j.ygyno.2004.07.063.

Abstract

Background: Low-grade endometrial stromal sarcoma is an indolent steroid responsive tumor. Successful hormonal treatment, most commonly with megestrol acetate, has been reported.

Case: A 76-year-old woman underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy 25 years earlier allegedly for a benign condition. She presented to us with postrenal kidney failure and a huge pelvic mass compressing both ureters. After transvaginal trough-cut biopsy of the mass, the diagnosis of low-grade endometrial stromal sarcoma with a high expression of alpha-estrogen receptor was made. The patient was treated with letrozole only with a spectacular response.

Conclusion: To the best of our knowledge, this is the first case for which letrozole was used on long-term basis as first-line hormonal treatment for a recurrent low-grade stromal sarcoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Aromatase Inhibitors / therapeutic use*
  • Female
  • Humans
  • Letrozole
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Nitriles / therapeutic use*
  • Sarcoma, Endometrial Stromal / drug therapy*
  • Sarcoma, Endometrial Stromal / pathology
  • Triazoles / therapeutic use*

Substances

  • Antineoplastic Agents
  • Aromatase Inhibitors
  • Nitriles
  • Triazoles
  • Letrozole